celecoxib has been researched along with Pouch Ileitis in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with Crohn's disease, ulcerative colitis, or pouchitis who used celecoxib or rofecoxib were identified from computerized prescription records." | 3.71 | Safety of selective cyclooxygenase-2 inhibitors in inflammatory bowel disease. ( Loftus, EV; Mahadevan, U; Sandborn, WJ; Tremaine, WJ, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mahadevan, U | 1 |
| Loftus, EV | 1 |
| Tremaine, WJ | 1 |
| Sandborn, WJ | 1 |
1 other study available for celecoxib and Pouch Ileitis
| Article | Year |
|---|---|
Safety of selective cyclooxygenase-2 inhibitors in inflammatory bowel disease.
Topics: Adult; Aged; Celecoxib; Colitis, Ulcerative; Crohn Disease; Cyclooxygenase 2; Cyclooxygenase 2 Inhib | 2002 |